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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A310with the reduced Mmp13 and Ptgs2 mRNA detected in the KO animals.
The contribution of Elf3 to load-induced cartilage damage and the
identiﬁcation of targets and mechanism of action in vivo merits further
investigation.
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INHIBITION OF CTX-II RELEASE BY CATHEPSIN K INHIBITION IN VIVO
BUT NOT IN VITRO SUGGESTS THAT ANTI-RESORPTIVE THERAPY
PROTECTS CARTILAGE
E. Lindstrom y, U. Grabowska y, N.A. Athanasou z, K. Fuller x,
T.J. Chambers x. yMedivir AB, Huddinge, Sweden; zBotnar Res. Ctr., Univ. of
Oxford, Oxford, United Kingdom; x St.George's, Univ. of London, London,
United Kingdom
Purpose: Loss of subchondral bone precedes both reduced joint space
in human OA and cartilage loss in animal models. This suggests that
resorption of subchondral bone might cause or aggravate cartilage loss.
Consistent with this, anti-resorptives given in vivo suppress release of
CTX-II, a peptide fragment generated from cleavage of type II collagen,
in several species and prevent disease progression in animal models
and in humans. Thus, loss of subchondral bonemay destabilise cartilage
and induce its degradation by chondrocytes. However, an alternative
explanation for suppression of CTX-II has recently been proposed i.e.
that osteoclasts themselves release CTX-II when they resorb calciﬁed
cartilage, so that there is less release when resorption is inhibited. We
therefore tested whether osteoclasts generate CTX-II from cartilage and
if this was done in a MMP- or cathepsin K-dependent manner. We used
osteoclast-induced CTX-I release from subchondral bone as a com-
parator.We also compared the in vitro datawith the effect of a cathepsin
K inhibitor in vivo on urine CTX-I and CTX-II levels in female beagle dogs
subjected to partial medial meniscectomy, an experimental model of
OA1.
Methods: For the in vitro study, human osteoclasts were incubated on
slices of subchondral bone and overlying calciﬁed and hyaline cartilage
(‘bone-cartilage’) taken from patients with OA. CTX-I and CTX-II levels
were measured after a ﬁrst incubation period for 24 h to establish a
baseline release of the two respective biomarkers. The cultures were
then incubated with the selective cathepsin K inhibitor MV061194 (300
nM, n¼4), or the broad spectrumMMP-inhibitor GM6001 (10 mM, n¼4),
or vehicle (n¼4) for another 24 h. Results were expressed as CTX-I or
CTX-II release compared to baseline. In a previously performed exper-
imental dog OA study, female beagle dogs were subjected to partial
medial meniscectomy and treated with the selective cathepsin K
inhibitor MIV-711 (30 mmol/kg p.o., n¼15) or vehicle (p.o., n¼15) for 28
days starting the day before surgery. Urine was collected for assessment
of CTX-I and CTX-II levels and creatinine. All data are expressed as mean
± SEM.
Results: Osteoclast incubation on the bone-cartilage slices increased
CTX-I levels from <LLQ (0.44 nM) to 155 ± 24 nM. CTX-II levels from the
same slices were increased from 34 ± 6 pg/ml to 533 ± 23 pg/ml. As
expected, the cathepsin K inhibitor MV061194 strongly suppressed
CTX-I release (vehicle controls: 76±13% compared to baseline;
MV061194: 26±4%). However, there was no change in CTX-II release in
presence of the cathepsin K inhibitor (vehicle controls: 92±5% com-
pared to baseline; MV061194: 88±8%). In contrast, the MMP inhibitor
GM6001 reduced CTX-II to 45±5% of baseline release. These data
however do not exclude that osteoclasts could release other cleavage
fragments from type II collagen in a cathepsin K-dependent manner. In
female beagle dogs, after 28-day treatment, the selective cathepsin K
inhibitor MIV-711 reduced urinary CTX-I levels to 14±1% compared to
baseline and CTX-II levels to 20±2%.
Conclusions: Osteoclasts release CTX-I and CTX-II from bone/cartilage
explants in vitro. The CTX-I release in vitro is cathepsin K-dependent
while the CTX-II release is not. By contrast, selective cathepsin K
inhibition reduces urinary levels of CTX-I and CTX-II in a similar fashion
in dog. In dog, these reductions translated into structural beneﬁt on
cartilage1. Thus, this provides evidence that the reduction in CTX-II in
vivo by cathepsin K inhibition is probably not caused by direct sup-
pression of osteoclast-evoked CTX-II release. Rather, direct inhibition of
cathepsin K-mediated bone resorption protects cartilage, and thereby
indirectly reduces the release of CTX-II.
Reference
1. Lindstr€om E, Vrang L, Sedig S, Terelius Y, Sahlberg B-L, Wikstr€om K,
Chambers TJ, Maul D, Bendele A, Grabowska U. Effect of the selective
cathepsin K inhibitor MIV-711 on markers of cartilage degradation andon gross and histopathology scores in dogs subjected to partial medial
meniscectomy, an experimental model of osteoarthritis. Osteoarthritis
and Cartilage 2011; 19(suppl 1): abs.112
490
KNEE KINEMATIC DIFFERENCES IN ANTERIOR CRUCIATE LIGAMENT
DEFICIENT SUBJECTS PRIOR TO RECONSTRUCTION IS ASSOCIATED
WITH KNEE T1r CARTILAGE RELAXATION TIME AT LONGITUDINAL
FOLLOW-UP
D. Wu y, H.-L. Teng z, F. Su z, A. Azus y, X. Li z, R. Souza z, B.C. Ma z. yUniv.
of California, Berkeley, Berkeley, CA, USA; zUniv. of California, San
Francisco, San Francisco, CA, USA
Purpose: This study aimed to identify possible biomechanical markers
in gait alterations in anterior cruciate ligament (ACL)-deﬁcient knees
prior to reconstruction to predict T1r relaxation times.
Methods: Subjects: Motion analysis data were recorded at baseline
(n¼49, female:male¼ 20:29, age: 29.63±8.63 years, BMI: 23.8±2.66 kg/
m2) after injury and before ACL reconstruction. Gait Analysis: At base-
line, three-dimensional motion analysis was captured while subjects
walked at a controlled speed (1.33±0.6667 m/s). Lower-extremity kin-
ematics data were recorded using AMTI force plate (Watertown, MA,
USA, sampling frequency ¼ 1000Hz) and Vicon motion capture system
(Oxford Metrics, UK, sampling frequency ¼ 250 Hz). Joint external
moments and impulses were then computed using Visual3D Software
(C-Motion, Germantown, MD, USA). MR Protocol: Of the 49 subjects
that conducted motion analysis at baseline, 39 patients returned 12
months following surgery to conduct MR imaging of both knees using a
3 Tesla scanner (GE healthcare) and an 8-channel knee coil (Invivo).
Comprehensive cartilage T1r relaxation times were calculated using
previously validated and published methods by our group. Cartilage
was divided into subcompartments to examine regional variations in
cartilage health (Figure 1). Mean T1r relaxation times were calculated
for each global compartment and its corresponding subcompartments.
Statistic Analysis: Pearson product correlation coefﬁcients were calcu-
lated between T1r relaxation times at the 12-month timepoint and gait
characteristics obtained at baseline prior to surgery Variables histor-
ically in literature that could be associated with knee osteoarthritis
were examined, such as peak knee extension adduction moments and
impulses, and hip ﬂexion moments.
Results: In injury knees, baseline lower peak hip ﬂexion moment, lower
peak knee extension moment in the 1st half of stance phase and lower
peak knee adduction moment in the 2nd half of stance phase were
signiﬁcantly correlated with increased cartilage T1p at 12-months.
(Table 1)
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A311In contralateral knees, baseline lower peak hip ﬂexion moment Lower
peak knee extension moment in the 1st half of stance phase and lower
peak knee adduction moment in the 2nd half of stance phase were
signiﬁcantly correlated with increased cartilage T1p at 12-months.
(Table 2)
Conclusions: The correlations observed between joint loading at
baseline and knee cartilage T1p at 12-month after surgery indicate that
baseline joint loading in the ACL-deﬁcient state may be a signiﬁcant
indicator and predictor of cartilage T1p 1 year after surgery. Our results
showed that there exist similar correlations in both the injured and
contralateral knee to cartilage health 1 year after surgery. A possible
explanation for this result is that certain individuals who character-
istically walk with greater loading in the knee during gait, speciﬁcally
with a higher extension and adduction moment are at higher risk of
causing degenerative changes in their cartilage, while higher loading in
the knee could potentially lower the risk of degenerating cartilage.
Cartilage T1p has been shown to show degenerative changes in carti-
lage health as soon as 1 year following ACL reconstruction, and these
results indicate that measuring hip and knee loading prior to ACL
reconstruction may predict cartilage health after ACL reconstruction.
This study was funded by NIH/NIAMS P50 AR060752.
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ENDOGENOUS HYDROGEN SULFIDE PRODUCTION IS REDUCED IN OA
CARTILAGE. POSSIBLE CONTRIBUTION TO THE PATHOGENESIS OF OA
A.A. Vela-Anero y, L. Gato-Calvo y, C. Ruiz-Romero y, R. Meijide-Failde z,
F.J. Blanco y, E.F. Burguera y. y INIBIC, A Coru~na, Spain; zUniv. of A Coru~na,
A Coru~na, Spain
Purpose: Hydrogen sulﬁde (H2S) is a newly discovered endogenous gas
(gasotransmitter) that is involved in many physiological processes.
Recent studies have also shown that some in pathologic situations such
as hypertension, cardiovascular disease or diabetes type II, H2S
endogenous levels are signiﬁcantly reduced. We hypothesize that this
might be the case also in osteoarthritis (OA). Therefore the purpose of
this study was to analyze the levels of hydrogen sulﬁde in blood serum,
its production from cartilage and the expression of its synthesizing
enzymes in the joint, comparing OA and non OA samples.
Methods: Tissue (cartilage, synovial membrane and subchondral bone)
and blood samples were obtained from patients of the Orthopedic or
Rheumatology Services of the University Hospital A Coru~na (CHUAC),
after written informed consent. The mRNA expression of the H2S pro-
duction enzymes, cystathionine b-synthase (CBS), cystathionine g-lyase
(CTH) and mercaptopyruvate sulfurtransferase (MPST) was analyzed in
cartilage, synovial membrane and subchondral bone. Based on the
obtained results, the presence of the enzymes was visualized in carti-
lage through immunohistochemistry and quantiﬁed with appropriate
software (ImageJ). Hydrogen sulﬁde concentration was measured using
a selective ion microelectrode. Direct H2S concentration in 200 mL of
fresh blood serum was measured after incubation with 200 mL of an
antioxidant buffer (AB) for 1h. Likewise, H2S production from cartilage
was measured by incubating cartilage discs (6mm in diameter, 3mm
height) in 200 mL of the same AB for 2 h. In both cases results in mV
were translated into H2S concentration (uM) using a calibration curve,
and normalized per ul of blood serum or mg of cartilage.
Results:With respect to the H2S production enzymes, we found that CBS
andCTHwereexpressed inall tested joint tissues.We founda tendency for
CBS to be reduced in the OA cartilage, but no statistically signiﬁcant dif-
ferences were detected in these enzymes in all tissues. However, inter-
estingly, MPST was only found to be expressed in cartilage, and its mRNA
expressionwas signiﬁcantly lower in OA cartilagewith respect to non OA
cartilage (Image 1). Immunohistochemistry also showed decreased levelsof this enzyme in cartilage. On the other hand, statistically signiﬁcant
differenceswerealso found in theH2Sproductionmeasured fromOAwith
respect to non OA cartilage samples. Indeed, OA cartilage H2S production
was 0.13 ± 0.03 uM/mg, n¼11 while that of healthy cartilage was 0.92 ±
0.42 uM/mg, n¼3 (mean ± SEM, p<0.05). Conversely, these results were
not reproduced in blood serum samples, where no statistically signiﬁcant
differences were found (OA serum: 0.37±0.05 uM/mL, n¼27 vs. N serum:
0.31±0.04 uM/mL, n¼31; mean ± SEM).
Conclusions: The current results show, for the ﬁrst time, that the levels
of the endogenous gasotransmitter H2S are reduced in OA cartilage
with respect to normal controls. Since endogenous H2S exerts anti-
inﬂammatory and anti-oxidant effects, the lower concentration and
production found here, might be contributing factors to the patho-
genesis of OA.
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SPONTANEOUS DEVELOPMENT OF SCLEROTIC CHANGES OF
SUBCHONDRAL BONE AND CARTILAGE DEGRADATION IN
ENDOTHELIN-1 OVEREXPRESSION TRANSGENIC MICE UPON HIGH
FAT/HIGH CHOLESTEROL DIET
P.B. Chan, C. Wen, C. Yan, K. Chiu. The Univ. of Hong Kong, Hong Kong,
Hong Kong
Purpose: Osteoarthritis has been found to be well correlated to meta-
bolic syndromes like hypertension and obesity but being a multifaceted
degenerative disease, many of the actual biochemical pathways remain
unsolved.
We have previously demonstrated the effect of endothelin-1, a potent
vasoconstrictor that contributes to hypertension, in the development of
osteoarthritic changes in the subchondral bone. This time, we would
like to investigate the interplay and biochemical roles of obesity and
endothelin-1 in osteoarthritis and propose the use of obese endothelin-
1 overexpressing mice as an OA model.
Methods: Male, 35-week-old endothelin-1 overexpressing (TET) mice
and their non-transgenic littermates were used in this study. Half of
each group was fed with high fat, high cholesterol chow to induce
obesity, and the other half was fed with normal chow.
Knee joints were harvested and ﬁxed in 10% formalin solution imme-
diately after sacriﬁce. Micro-CT scans of the knee joints were performed
before tissue processing. Subchondral bone structures were analysed in
CTAn Software.
Samples were embedded for parafﬁn sectioning at 5mm at sagittal
plane.
Safranin-O staining was done to evaluate the cartilage degeneration
indicated by loss of glycosaminoglycan content.
Immunohistochemical staining was performed using rabbit primary
antibodies coupled with Streptavidin-HRP developed with DAB sub-
strate, and counterstained with Harris Haematoxylin.
Results: TET mice fed with high fat & high cholesterol diet were found
to have higher bone volume fraction (43.3% vs 36.3%) and lower bone
